Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1

Journal of Virology

Volumn 74, Issue 2, 2000, Pages 892-898

  Taube, Ran ^a   Fujinaga, Koh ^a   Irwin, Dan ^a   Wimmer, Jörg ^a   Geyer, Matthias ^a   Peterlin, B Matija ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; LEUCINE; TRANSACTIVATOR PROTEIN; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOG; EQUINE INFECTIOUS ANEMIA VIRUS; HELA CELL; HORSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS TRANSCRIPTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CYCLINS; DOGS; GENE PRODUCTS, TAT; HELA CELLS; HORSES; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE; LEUCINE; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; SEQUENCE HOMOLOGY, AMINO ACID; TERMINAL REPEAT SEQUENCES; TRANS-ACTIVATION (GENETICS); VALINE;

EID: 0033986157     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.2.892-898.2000     Document Type: Article

References (31)

1. Andersen, G., D. Busso, A. Poterszman, J. R. Hwang, J. M. Wurtz, R. Ripp, J. C. Thierry, J. M. Egly, and D. Moras. 1997. The structure of cyclin H: common mode of kinase activation and specific features. EMBO J. 16:958-967.
2. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1999. Highly divergent lentiviral Tat proteins activate viral gene expression. Mol. Cell. Biol. 19:4592-4599.
3. Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17:7055-7065.
4. Carroll, R., L. Martarano, and D. Derse. 1991. Identification of lentivirus Tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J. Virol. 65:3460-3467.
5. Carroll, R., B. M. Peterlin, and D. Derse. 1992. Inhibition of human immunodeficiency virus type 1 Tat activity by coexpression of heterologous trans-activators, J. Virol. 66:2000-2007.
6. Carvalho, M., and D. Derse. 1993. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter. J. Virol. 67:2064-2074.
7. Carvalho, M., and D. Derse. 1991. Mutational analysis of the equine infectious anemia virus Tat-responsive element. J. Virol. 65:3468-3474.
8. Cujec, T. P., H. Cho, E. Maldonado, J. Meyer, D. Reinberg, and B. M. Peterlin. 1997. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol. 17:1817-1823.
9. Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. Morgan, and B. M. Peterlin. 1997. The HIV transactivator Tat hinds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1-12.
10. Derse, D., R. Carroll, M. Cavalho, L. DaSilva, and L. Martarano. 1991. Functional topography of lentivirus Tat proteins defined by domain switching, p. 251-261. In W. A. Haseltine and F. Wong-Staal (ed.), Genetic structure and regulation of HIV. Raven Press, New York, N.Y.
11. Derse, D., and S. H. Newbold. 1993. Mutagenesis of EIAV Tat reveals structural features essential for transcriptional activation and TAR element recognition. Virology 194:530-536.
12. Derse, D., M. Carvalho, R. Carroll, and B. M. Peterlin. 1991. A minimal lentivirus Tat. J. Virol. 65:7012-7015.
13. Derse, D., P. Dorn, L. DaSilva, and L. Martarano. 1990. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat). Dev. Biol. Stand. 72:39-48.
14. Derse, D., P. L. Dorn, L. Levy, R. M. Stephens, N. R. Rice, and J. W. Casey. 1987. Characterization of equine infectious anemia virus long terminal repeat. J. Virol. 61:743-747.
15. Dorn, P., L. DaSilva, L. Martarano, and D. Derse. 1990. Equine infectious anemia virus Tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J. Virol. 64:1616-1624.
16. Dorn, P. L., and D. Derse. 1988. cis-and trans-acting regulation of gene expression of equine infectious anemia virus. J. Virol. 62:3522-3526.
17. Fujinaga, K., T. P. Cujec, J. Peng, J. Garriga, D. H. Price, X. Grana, and B. M. Peterlin. 1998. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72:7154-7159.
18. Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96:1285-1290.
19. Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:3512-3527.
20. Herrmann, C., and A. Rice. 1993. Specific interactions of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology 197: 601-608.
21. Ivanov, D., Y. T. Kwak, E. Nee, J. Guo, L. F. Garcia-Martinez, and R. B. Gaynor. 1999. Cyclin T1 domains involved in complex formation with Tat and TAR RNA. J. Mol. Biol. 288:41-56.
22. Jones, K. A. 1997. Taking a new TAK on Tat transactivation. Genes Dev. 11:2593-2599.
23. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
24. Kraulis, P. J. 1991. MOLSCRIPT, a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-950.
25. Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 Tat. J. Mol. Biol. 288:57-69.
26. Madore, S. J., and B. R. Cullen. 1993. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J. Virol. 67:3703-3711.
27. Maury, W. 1998. Regulation of equine infectious anemia virus expression. J. Biomed. Sci. 5:11-23.
28. Noiman, S., A. Gazit, O. Tori, L. Sherman, T. Miki, S. R. Tronick, and A. Yaniv. 1990. Identification of sequences encoding the equine infectious anemia virus tat gene. Virology 176:280-288.
29. Peitsch, M. C. 1996. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:274-279.
30. Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:755-762.
31. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.